DOTmed September 4, 2024
McKesson Corporation has announced a definitive agreement to acquire a 70% controlling interest in Community Oncology Revitalization Enterprise (CORE) Ventures, a business and administrative services organization established by a physician-owned oncology practice, Florida Cancer Specialists & Research Institute (FCS).
The deal, valued at approximately $2.49 billion in cash, is aimed at integrating Core Ventures into McKesson’s Oncology platform, and financial results will be reported within McKesson’s US Pharmaceutical segment.
Following the close of the transaction, FCS, a practice with more than 250 physicians and 280 advanced practice providers, across nearly 100 locations in Florida, will remain independently owned and join McKesson’s The US Oncology...
Today's Sponsors
Today's Sponsor